Clinical trial
Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment
NCT00061347 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00061347 |
|---|---|
| Title | Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment |
| Official title | Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Cancer |
| Intervention type | Procedure |
| Interventions | Fiducial marker placement |
| Enrollment | 15 |
| Start date | May 23, 2003 |
| Primary completion | May 31, 2004 |
| Completion | Apr 19, 2018 |
| First posted | May 26, 2003 |
| Last update posted | Apr 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: